Daniel Reirden
ORCID: 0000-0002-4391-2718Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial”.
Brett Hanscom, Zhe Wang, Steven A. Safren, Christina Psaros, Deborah Donnell +61 more
Claire Burke Draucker, J. Dennis Fortenberry, Mary A. Ott, Renata Arrington‐Sanders, Daniel Reirden +6 more
Mary A. Ott, Claire Burke Draucker, J. Dennis Fortenberry, Daniel Reirden, Renata Arrington‐Sanders +6 more
Todd T. Brown, Aleshia Thomas, Joseph J. Eron, Athe Tsibris, Andrea Weiss +82 more
Zaynab Essack, Katherine Byron, Catherine Slack, Daniel Reirden, Heidi van Rooyen +3 more
Anna Furniss, Samuel Cortez, Shanlee Davis, Nadia Dowshen, Anne E. Kazak +7 more
Megan Mueller Johnson, Heather M. Tucker, Michael G. Hudgens, Ronald H. Dallas, Keith J. Horvath +10 more